Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
249 questions in 68 reviews · Airways
current versionsNo studies 249 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Remote monitoring plus usual care vs usual care Quality of life · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Multi‐component interventions (with telehealth as a component of care) vs usual care Dyspnoea symptoms · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Multi‐component interventions (with telehealth as a component of care) vs usual care No evidence identified · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Multi‐component interventions (with telehealth as a component of care) vs usual care Mortality · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring plus usual care vs usual care Dyspnoea symptoms · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Remote monitoring plus usual care vs usual care No evidence identified · people with chronic obstructive pulmonary disease Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary… (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention vs usual care Outcome domain · COPD and at least one other long‐term condition Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one… (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention vs active comparison Quality of life ‐ CAT total · COPD and at least one other long‐term condition Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one… (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention vs active comparison Exacerbations · COPD and at least one other long‐term condition Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one… (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention vs active comparison All‐cause hospital admissions · COPD and at least one other long‐term condition Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one… (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention vs active comparison All‐cause mortality · COPD and at least one other long‐term condition Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one… (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention vs active comparison Outcome domain · COPD and at least one other long‐term condition Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one… (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention vs active comparison Quality of life ‐ SGRQ total · COPD and at least one other long‐term condition Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one… (2021) · Cochrane | no estimate extracted | NR | No studies |
Individual level interventions vs control Respiratory exacerbations · healthy individuals and those with a pre‐existing health condition Individual‐level interventions to reduce personal exposure to outdoor air pollution and their effects on… (2021) · Cochrane | no estimate extracted | NR | No studies |
Individual level interventions vs control Quality of life · healthy individuals and those with a pre‐existing health condition Individual‐level interventions to reduce personal exposure to outdoor air pollution and their effects on… (2021) · Cochrane | no estimate extracted | NR | No studies |
Individual level interventions vs control Serious adverse events · healthy individuals and those with a pre‐existing health condition Individual‐level interventions to reduce personal exposure to outdoor air pollution and their effects on… (2021) · Cochrane | no estimate extracted | NR | No studies |
Supervised maintenance programme following pulmonary rehabilitation vs usual care Outcomes · chronic obstructive pulmonary disease Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic… (2021) · Cochrane | no estimate extracted | NR | No studies |
Breathing exercises vs inactive control Inpatient hospitalisation episodes · adults with asthma Breathing exercises for adults with asthma (2020) · Cochrane | no estimate extracted | NR | No studies |
Breathing exercises vs inactive control Days off work · adults with asthma Breathing exercises for adults with asthma (2020) · Cochrane | no estimate extracted | NR | No studies |
Titrated oxygen therapy vs high‐flow oxygen therapy Quality of life ‐ not measured · adults with acute exacerbations of chronic obstructive pulmonary disease Oxygen therapy in the pre‐hospital setting for acute exacerbations of chronic obstructive pulmonary disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Titrated oxygen therapy vs high‐flow oxygen therapy Lung function ‐ not measured · adults with acute exacerbations of chronic obstructive pulmonary disease Oxygen therapy in the pre‐hospital setting for acute exacerbations of chronic obstructive pulmonary disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Titrated oxygen therapy vs high‐flow oxygen therapy Dyspnoea score ‐ not measured · adults with acute exacerbations of chronic obstructive pulmonary disease Oxygen therapy in the pre‐hospital setting for acute exacerbations of chronic obstructive pulmonary disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Montelukast vs placebo Serious adverse events (N experiencing event) · obstructive sleep apnoea in children Anti‐inflammatory medications for obstructive sleep apnoea in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Serious adverse events (N experiencing events) · obstructive sleep apnoea in children Anti‐inflammatory medications for obstructive sleep apnoea in children (2020) · Cochrane | no estimate extracted | NR | No studies |
Sublingual immunotherapy vs control Quality of life · adults and children with asthma Sublingual immunotherapy for asthma (2020) · Cochrane | no estimate extracted | NR | No studies |
PPI plus usual care vs usual care alone or chronic obstructive pulmonary disease Pneumonia and other serious adverse events · chronic obstructive pulmonary disease Proton pump inhibitors for chronic obstructive pulmonary disease (2020) · Cochrane | no estimate extracted | NR | No studies |
PPI plus usual care vs usual care alone or chronic obstructive pulmonary disease Quality of life · chronic obstructive pulmonary disease Proton pump inhibitors for chronic obstructive pulmonary disease (2020) · Cochrane | no estimate extracted | NR | No studies |
PPI plus usual care vs usual care alone or chronic obstructive pulmonary disease Lung function indices · chronic obstructive pulmonary disease Proton pump inhibitors for chronic obstructive pulmonary disease (2020) · Cochrane | no estimate extracted | NR | No studies |
PPI plus usual care vs usual care alone or chronic obstructive pulmonary disease Disease‐specific adverse events · chronic obstructive pulmonary disease Proton pump inhibitors for chronic obstructive pulmonary disease (2020) · Cochrane | no estimate extracted | NR | No studies |
Atorvastatin vs placebo Asthma exacerbations requiring hospitalisation or a course of steroids · people with asthma Statins for asthma (2020) · Cochrane | no estimate extracted | NR | No studies |
Atorvastatin vs placebo Health‐related quality of life · people with asthma Statins for asthma (2020) · Cochrane | no estimate extracted | NR | No studies |
Atorvastatin vs placebo Serious adverse events or adverse events · people with asthma Statins for asthma (2020) · Cochrane | no estimate extracted | NR | No studies |
Mucolytic vs placebo Outcomes* · chronic bronchitis or COPD Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Bi‐PAP vs fixed CPAP Machine usage assessed by number of participants using machine for 4 or more hours per night ‐ not measured · adults with a diagnosis of sleep apnoea Pressure modification or humidification for improving usage of continuous positive airway pressure machines… (2019) · Cochrane | no estimate extracted | NR | No studies |
Bi‐PAP vs fixed CPAP Blood pressure ‐ not measured · adults with a diagnosis of sleep apnoea Pressure modification or humidification for improving usage of continuous positive airway pressure machines… (2019) · Cochrane | no estimate extracted | NR | No studies |
CPAP with expiratory pressure relief vs fixed CPAP Machine usage assessed by number of participants using machine for 4 or more hours per night ‐ not measured · adults with a diagnosis of sleep apnoea Pressure modification or humidification for improving usage of continuous positive airway pressure machines… (2019) · Cochrane | no estimate extracted | NR | No studies |
CPAP with expiratory pressure relief vs fixed CPAP Blood pressure ‐ not measured · adults with a diagnosis of sleep apnoea Pressure modification or humidification for improving usage of continuous positive airway pressure machines… (2019) · Cochrane | no estimate extracted | NR | No studies |
Heated humidification + fixed CPAP vs fixed CPAP alone Machine usage assessed by number of participants using machine for 4 or more hours per night ‐ not measured · adults with a diagnosis of sleep apnoea Pressure modification or humidification for improving usage of continuous positive airway pressure machines… (2019) · Cochrane | no estimate extracted | NR | No studies |
Heated humidification + fixed CPAP vs fixed CPAP alone Quality of life · adults with a diagnosis of sleep apnoea Pressure modification or humidification for improving usage of continuous positive airway pressure machines… (2019) · Cochrane | no estimate extracted | NR | No studies |
Heated humidification + fixed CPAP vs fixed CPAP alone Blood pressure ‐ not measured · adults with a diagnosis of sleep apnoea Pressure modification or humidification for improving usage of continuous positive airway pressure machines… (2019) · Cochrane | no estimate extracted | NR | No studies |
Group 3 Pulmonary hypertension due to lung disease ‐ PDE5i vs placebo Mortality · people with pulmonary hypertension due to lung disease Phosphodiesterase 5 inhibitors for pulmonary hypertension (2019) · Cochrane | no estimate extracted | NR | No studies |
Mixed Pulmonary hypertension group 2 ‐ 4 ‐ PDE5i vs placebo Mortality · people with pulmonary hypertension group 2 ‐ 4 Phosphodiesterase 5 inhibitors for pulmonary hypertension (2019) · Cochrane | no estimate extracted | NR | No studies |
Mixed Pulmonary hypertension group 2 ‐ 4 ‐ PDE5i vs placebo Quality of life · people with pulmonary hypertension group 2 ‐ 4 Phosphodiesterase 5 inhibitors for pulmonary hypertension (2019) · Cochrane | no estimate extracted | NR | No studies |
Quinolone vs macrolide Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · chronic obstructive pulmonary disease Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Macrolide vs tetracycline Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · chronic obstructive pulmonary disease Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Macrolide+tetracycline vs macrolide Number of people experiencing one or more exacerbations, Drug resistance/microbial sensitivity (as reported by trialists), including emergence of atypical bacteria, Number of participants colonised with Pseudomonas aeruginosa · chronic obstructive pulmonary disease Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Quinolone vs tetracycline Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · chronic obstructive pulmonary disease Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease (2019) · Cochrane | no estimate extracted | NR | No studies |
Influenza vaccine vs placebo Days disability from respiratory illness · chronic obstructive pulmonary disease (COPD) Influenza vaccine for chronic obstructive pulmonary disease (COPD) (2018) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs placebo or usual care ICU/HDU admission ‐ not reported · acute asthma exacerbation Antibiotics for exacerbations of asthma (2018) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs placebo or usual care Mortality ‐ not reported · acute asthma exacerbation Antibiotics for exacerbations of asthma (2018) · Cochrane | no estimate extracted | NR | No studies |